Literature DB >> 19571796

A transcranial magnetic stimulation study of the effects of cannabis use on motor cortical inhibition and excitability.

Paul B Fitzgerald1, Suzanne Williams, Zafiris J Daskalakis.   

Abstract

Active compounds in cannabis such as tetrahydrocannabinol (THC) interact with the inhibitory neurotransmitter delta-aminobutyric acid (GABA) but little is known about the functional effects of cannabis on human cortical brain processes. Therefore, the aim of the study was to investigate whether patients with chronic cannabis use demonstrate abnormalities in cortical inhibition or excitability. In all, 42 chronic cannabis using subjects (divided into heavy and light using subjects) and 19 controls were included in the study. Single and paired pulse transcranial magnetic stimulation were used to assess a number of parameters of cortical inhibition and cortical excitability. In addition, psychomotor function and THC plasma levels were measured. Both cannabis using groups (heavy and light use) demonstrated a reduction in short interval cortical inhibition compared with healthy controls, but there was no difference in other measures of cortical inhibition or cortical excitability. There was also no difference between the two groups on measures of psychomotor performance. Chronic cannabis use is associated with a reduction in cortical inhibition potentially related to activity at the GABA(A) receptors. Further research is required to explore whether this results from chronic cannabis use or reflects an underlying predisposition to developing chronic substance use problems.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19571796     DOI: 10.1038/npp.2009.71

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  12 in total

Review 1.  Inhibition of the cortex using transcranial magnetic stimulation in psychiatric populations: current and future directions.

Authors:  Natasha Radhu; Lakshmi N Ravindran; Andrea J Levinson; Zafiris J Daskalakis
Journal:  J Psychiatry Neurosci       Date:  2012-11       Impact factor: 6.186

Review 2.  Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis.

Authors:  Richard S Bedlack; Nanette Joyce; Gregory T Carter; Sabrina Paganoni; Chafic Karam
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

3.  Disrupted gamma-band neural oscillations during coherent motion perception in heavy cannabis users.

Authors:  Patrick D Skosnik; Giri P Krishnan; Deepak C D'Souza; William P Hetrick; Brian F O'Donnell
Journal:  Neuropsychopharmacology       Date:  2014-07-03       Impact factor: 7.853

Review 4.  Brain Stimulation in Addiction.

Authors:  Michael C Salling; Diana Martinez
Journal:  Neuropsychopharmacology       Date:  2016-05-31       Impact factor: 7.853

5.  Exogenous and endogenous cannabinoids suppress inhibitory neurotransmission in the human neocortex.

Authors:  Flora E Kovacs; Tim Knop; Michal J Urbanski; Ilka Freiman; Thomas M Freiman; Thomas J Feuerstein; Josef Zentner; Bela Szabo
Journal:  Neuropsychopharmacology       Date:  2011-11-02       Impact factor: 7.853

6.  Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse.

Authors:  Thomas Wobrock; Alkomiet Hasan; Berend Malchow; Claus Wolff-Menzler; Birgit Guse; Nicolas Lang; Thomas Schneider-Axmann; Ullrich K H Ecker; Peter Falkai
Journal:  Psychopharmacology (Berl)       Date:  2009-12-09       Impact factor: 4.530

7.  A Systematic Review of Long-Interval Intracortical Inhibition as a Biomarker in Neuropsychiatric Disorders.

Authors:  Parmis Fatih; M Utku Kucuker; Jennifer L Vande Voort; Deniz Doruk Camsari; Faranak Farzan; Paul E Croarkin
Journal:  Front Psychiatry       Date:  2021-06-02       Impact factor: 4.157

Review 8.  Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence.

Authors:  Berend Malchow; Alkomiet Hasan; Paolo Fusar-Poli; Andrea Schmitt; Peter Falkai; Thomas Wobrock
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-08-21       Impact factor: 5.270

Review 9.  Repetitive transcranial magnetic stimulation as a potential treatment approach for cannabis use disorder.

Authors:  Tonisha Kearney-Ramos; Margaret Haney
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2021-03-04       Impact factor: 5.201

Review 10.  rTMS in the treatment of drug addiction: an update about human studies.

Authors:  Elisa Bellamoli; Paolo Manganotti; Robert P Schwartz; Claudia Rimondo; Maurizio Gomma; Giovanni Serpelloni
Journal:  Behav Neurol       Date:  2014-01-23       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.